annual total liabilities:
$1.54B+$326.41M(+26.96%)Summary
- As of today (June 28, 2025), CYTK annual total liabilities is $1.54 billion, with the most recent change of +$326.41 million (+26.96%) on December 31, 2024.
- During the last 3 years, CYTK annual total liabilities has risen by +$939.59 million (+157.26%).
- CYTK annual total liabilities is now at all-time high.
Performance
CYTK Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$1.53B-$6.58M(-0.43%)Summary
- As of today (June 28, 2025), CYTK quarterly total liabilities is $1.53 billion, with the most recent change of -$6.58 million (-0.43%) on March 1, 2025.
- Over the past year, CYTK quarterly total liabilities has increased by +$326.22 million (+27.09%).
- CYTK quarterly total liabilities is now -0.43% below its all-time high of $1.54 billion, reached on December 31, 2024.
Performance
CYTK quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CYTK Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.0% | +27.1% |
| 3 y3 years | +157.3% | +106.8% |
| 5 y5 years | +411.1% | +406.3% |
CYTK Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +157.3% | -0.4% | +131.8% |
| 5 y | 5-year | at high | +411.1% | -0.4% | +406.3% |
| alltime | all time | at high | >+9999.0% | -0.4% | >+9999.0% |
CYTK Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.53B(-0.4%) |
| Dec 2024 | $1.54B(+27.0%) | $1.54B(+6.0%) |
| Sep 2024 | - | $1.45B(+2.5%) |
| Jun 2024 | - | $1.42B(+17.5%) |
| Mar 2024 | - | $1.20B(-0.5%) |
| Dec 2023 | $1.21B(+7.8%) | $1.21B(+2.6%) |
| Sep 2023 | - | $1.18B(+6.0%) |
| Jun 2023 | - | $1.11B(-0.5%) |
| Mar 2023 | - | $1.12B(-0.3%) |
| Dec 2022 | $1.12B(+87.9%) | $1.12B(+2.8%) |
| Sep 2022 | - | $1.09B(+65.4%) |
| Jun 2022 | - | $660.30M(-10.8%) |
| Mar 2022 | - | $739.99M(+23.9%) |
| Dec 2021 | $597.46M(+42.1%) | $597.46M(+3.3%) |
| Sep 2021 | - | $578.52M(+5.6%) |
| Jun 2021 | - | $547.81M(+7.6%) |
| Mar 2021 | - | $509.22M(+21.1%) |
| Dec 2020 | $420.42M(+39.8%) | $420.42M(+29.6%) |
| Sep 2020 | - | $324.51M(+4.5%) |
| Jun 2020 | - | $310.57M(+2.7%) |
| Mar 2020 | - | $302.29M(+0.5%) |
| Dec 2019 | $300.75M(+62.4%) | $300.75M(+45.1%) |
| Sep 2019 | - | $207.26M(+2.0%) |
| Jun 2019 | - | $203.11M(+4.0%) |
| Mar 2019 | - | $195.24M(+5.4%) |
| Dec 2018 | $185.24M(+0.1%) | $185.24M(+3.9%) |
| Sep 2018 | - | $178.21M(+3.6%) |
| Jun 2018 | - | $172.07M(-4.6%) |
| Mar 2018 | - | $180.33M(-2.5%) |
| Dec 2017 | $184.97M(+144.1%) | $184.97M(+3.2%) |
| Sep 2017 | - | $179.28M(+8.2%) |
| Jun 2017 | - | $165.63M(-2.6%) |
| Mar 2017 | - | $169.99M(+124.3%) |
| Dec 2016 | $75.78M(+62.5%) | $75.78M(+1.1%) |
| Sep 2016 | - | $74.92M(+30.5%) |
| Jun 2016 | - | $57.41M(+3.8%) |
| Mar 2016 | - | $55.31M(+18.6%) |
| Dec 2015 | $46.65M(+14.0%) | $46.65M(+33.7%) |
| Sep 2015 | - | $34.90M(-7.8%) |
| Jun 2015 | - | $37.84M(-0.6%) |
| Mar 2015 | - | $38.06M(-6.9%) |
| Dec 2014 | $40.90M | $40.90M(+201.8%) |
| Sep 2014 | - | $13.55M(-22.3%) |
| Jun 2014 | - | $17.45M(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $21.10M(-26.6%) |
| Dec 2013 | $28.75M(+285.0%) | $28.75M(-40.4%) |
| Sep 2013 | - | $48.26M(+13.4%) |
| Jun 2013 | - | $42.57M(+580.0%) |
| Mar 2013 | - | $6.26M(-16.2%) |
| Dec 2012 | $7.47M(+62.5%) | $7.47M(+57.4%) |
| Sep 2012 | - | $4.74M(+15.7%) |
| Jun 2012 | - | $4.10M(-9.4%) |
| Mar 2012 | - | $4.52M(-1.5%) |
| Dec 2011 | $4.59M(-38.5%) | $4.59M(-8.7%) |
| Sep 2011 | - | $5.03M(-8.6%) |
| Jun 2011 | - | $5.50M(-9.4%) |
| Mar 2011 | - | $6.08M(-18.7%) |
| Dec 2010 | $7.48M(-64.7%) | $7.48M(+10.0%) |
| Sep 2010 | - | $6.80M(-7.7%) |
| Jun 2010 | - | $7.36M(-59.7%) |
| Mar 2010 | - | $18.26M(-13.8%) |
| Dec 2009 | $21.17M(-43.8%) | $21.17M(-2.9%) |
| Sep 2009 | - | $21.81M(-12.8%) |
| Jun 2009 | - | $25.00M(-45.3%) |
| Mar 2009 | - | $45.73M(+21.3%) |
| Dec 2008 | $37.69M(-32.0%) | $37.69M(-11.8%) |
| Sep 2008 | - | $42.74M(-8.6%) |
| Jun 2008 | - | $46.78M(-9.5%) |
| Mar 2008 | - | $51.71M(-6.7%) |
| Dec 2007 | $55.45M(-12.3%) | $55.45M(-6.3%) |
| Sep 2007 | - | $59.20M(-3.7%) |
| Jun 2007 | - | $61.48M(-5.5%) |
| Mar 2007 | - | $65.05M(+2.9%) |
| Dec 2006 | $63.20M(+253.1%) | $63.20M(+231.6%) |
| Sep 2006 | - | $19.06M(+13.5%) |
| Jun 2006 | - | $16.79M(+7.5%) |
| Mar 2006 | - | $15.62M(-12.7%) |
| Dec 2005 | $17.90M(-12.9%) | $17.90M(+1.3%) |
| Sep 2005 | - | $17.68M(+1.9%) |
| Jun 2005 | - | $17.34M(-14.5%) |
| Mar 2005 | - | $20.29M(-1.3%) |
| Dec 2004 | $20.55M(-86.7%) | $20.55M(-0.0%) |
| Sep 2004 | - | $20.55M(-4.3%) |
| Jun 2004 | - | $21.48M(-86.0%) |
| Mar 2004 | - | $153.50M(-0.9%) |
| Dec 2003 | $154.90M(+32.7%) | $154.90M |
| Dec 2002 | $116.76M(+0.3%) | - |
| Dec 2001 | $116.37M(+40.4%) | - |
| Dec 2000 | $82.86M | - |
FAQ
- What is Cytokinetics Incorporated annual total liabilities?
- What is the all time high annual total liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual total liabilities year-on-year change?
- What is Cytokinetics Incorporated quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly total liabilities year-on-year change?
What is Cytokinetics Incorporated annual total liabilities?
The current annual total liabilities of CYTK is $1.54B
What is the all time high annual total liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual total liabilities is $1.54B
What is Cytokinetics Incorporated annual total liabilities year-on-year change?
Over the past year, CYTK annual total liabilities has changed by +$326.41M (+26.96%)
What is Cytokinetics Incorporated quarterly total liabilities?
The current quarterly total liabilities of CYTK is $1.53B
What is the all time high quarterly total liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly total liabilities is $1.54B
What is Cytokinetics Incorporated quarterly total liabilities year-on-year change?
Over the past year, CYTK quarterly total liabilities has changed by +$326.22M (+27.09%)